Accessibility StatementSkip Navigation MENLO PARK, Calif., Sept. 10, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 2 Annual Healthcare Forum on Wednesday, Sep. 24 at 8:00 a.m. ET. Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast wil ...

About GRAIL MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, Aug. 13 at 8:30 a.m. ET. Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at leas ...

MENLO PARK, Calif., July 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the second quarter 2025 following the close of market on Tuesday, Aug. 12, 2025. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and business progress. A link to the live webcast and recorded replay will be ava ...

公司动态 - GRAIL公司管理层将于2025年6月4日美国东部时间上午11:40在纽约举行的Jefferies全球医疗保健会议上进行演讲 [1] - 会议的网络直播和回放可在GRAIL官网投资者关系栏目中获取 回放将在活动结束后至少保留30天 [2] 公司介绍 - GRAIL是一家专注于早期癌症检测的医疗保健公司 其使命是在癌症可治愈阶段进行早期发现 [3] - 公司致力于通过新一代测序技术、大规模临床研究和先进的机器学习、软件及自动化技术来减轻全球癌症负担 [3] - GRAIL的甲基化靶向平台可支持从筛查到精准肿瘤学的全程护理 包括有症状患者的多癌早期检测、风险分层、微小残留病灶检测、生物标志物亚型分析以及治疗和复发监测 [3] - 公司总部位于加利福尼亚州门洛帕克 在华盛顿特区、北卡罗来纳州和英国设有分支机构 [3] 其他信息 - 更多信息可访问公司官网grailcom [4]

公司财务发布安排 - 公司将于2025年5月13日美股市场收盘后发布2025年第一季度财务业绩 [1] - 管理层将在太平洋时间下午1:30（东部时间下午4:30）举行网络直播和电话会议讨论业绩及业务进展 [1] 投资者交流活动细节 - 网络直播链接及回放将在公司官网投资者关系页面提供 [2] - 需通过指定网址提前注册参与实时活动 [2] - 建议提前10分钟接入以确保及时连接 [3] 公司业务与技术 - 公司专注于通过早期癌症检测降低全球癌症负担 [4] - 核心技术结合新一代测序、大规模临床研究及先进机器学习与自动化软件 [4] - 甲基化靶向平台覆盖筛查至精准肿瘤全流程 包括多癌种早期检测、风险分层、微小残留病灶监测等 [4] 公司运营布局 - 总部位于加州门洛帕克 并在华盛顿特区、北卡罗来纳州及英国设有分支机构 [4]